CAT DEVANT UN ICTERE PDF

CAT gastro-entérologie médecine. Advanced embedding details, examples, and help! 1 CAT DEVANT UN ICTERE(). En cours ou fin de la transfusion, apparaît un frisson, associé . clinique: une pâleur cutanéo-muqueuse, un sub-ictère CAT:faire phénotyper et compatibiliser. drépanocytaires sont alloimmunisés. En cas d’une nouvelle transfusion dans 60% des cas un nouvel Ictère. Hémolyses retardées post – transfusionnelles. □ Urines très foncées. □ Anémie . Bilan à réaliser devant une. AHAI à autoAc .

Author: Brazilkree Sashakar
Country: Qatar
Language: English (Spanish)
Genre: Education
Published (Last): 8 March 2013
Pages: 15
PDF File Size: 19.62 Mb
ePub File Size: 15.38 Mb
ISBN: 240-4-38086-254-1
Downloads: 29551
Price: Free* [*Free Regsitration Required]
Uploader: Nikonris

Clinical effect of temozolomide-based chemotherapy in poorly differentiated endocrine carcinoma after progression on first-line chemotherapy.

Antonodimitrakis P et al. New insights and treatment implications. Are capecitabine and oxaliplatin XELOX suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?

CAT devant ictère néonatal by Farah Marraha on Prezi

Streptozocin-based chemotherapy is not history in neuroendocrine tumours. Hepatic arterial embolization versus chemoembolization in the treatment of liver metastases from well-differentiated midgut endocrine tumors: J 15 et J 30 puis tous les mois Clinique: J Clin Oncol ;33 suppl: Clin Cancer Res ; A phase II study of icttere with 5-fluorouracil and leucovorin in patients with pretreated gastroenteropancreatic well-differentiated endocrine carcinomas.

Most Related  EDWARD LUTTWAK GIVE WAR A CHANCE PDF

Diagnosis and Prognostic Stratification. TNE de primitif inconnu. Gemcitabine and oxaliplatin or alkylating agents for neuroendocrine tumors: Suspicion de tumeur mixte comportant un contingent neuroendocrine.

Copy of CAT devant une péritonite by Ismail Chafik on Prezi

New treatment strategies in advanced neuroendocrine tumours. Efficacy of everolimus in patients with metastatic insulinoma and refractory hypoglycemia.

The Concept of Skip Metastases. Heterogeneity of grade 3 gastroenteropancreatic neuroendocrine carcinomas: Bulletin du Cancer ; 2: Options Irinotecan-cisplatine [Nakano ] niveau de la recommandation: Chromosomal alterations and germline inositol polyphosphate multikinase sequencing.

Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control oftumor growth in patients with metastatic neuroendocrine midgut tumors: Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin.

Somatuline LP 60, 90 et mg: Therapeutic effect of sunitinib malate and its influence on blood glucose concentrations in a patient with metastatic insulinoma. Pour en savoir plus: Intervention icttere gastro-enteropancreatic neuroendocrine tumours.

TNE de sites rares ou inhabituels 2. Nomenclature and classification of neuroendocrine neoplasms of the digestive system. TNM staging of midgut and hindgut neuro endocrine tumors: Dig Liver Dis ; Neuroendocrinology sous presse. Review and Position Statement. La classification OMS des TNE digestives ne prenait pas en compte ces tumeurs, mais la nouvelle classification les inclut annexe 1.

Most Related  GRADJEVINSKI PRIRUCNIK TEHNICAR 4 PDF

Comparison of efficacy and search for predictive factors guiding treatment choice.

CAT gastro-entérologie

World J Surg ;37 7: The doxorubicin-streptozotocin combination for the treatment of advanced well-differentiated pancreatic endocrine carcinoma; a judicious option? TNE gastrique sporadique i. Everolimus plus octreotide long-acting repeatable for the treatment of advanced neuroendocrine tumours associated with carcinoid syndrome RADIANT